MedTrace Logo

Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

NCT05915897 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-04-18

No results posted yet for this study

Summary

The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Chronic Granulomatous Disease (CGD). The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

Conditions

  • Chronic Granulomatous Disease

Interventions

DIAGNOSTIC_TEST

Specimen Donation

blood donation

Sponsors & Collaborators

  • Sanguine Biosciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2024-03-25
Completion
2024-03-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05915897 on ClinicalTrials.gov